SCHEMBL16454855

SCHEMBL16454855

Cc1cccc(NC(=O)c2cccn3c(-c4ccncc4)nnc23)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.50
▸ PIK3CA P42336 1/20 0.50
▸ PIK3CB P42338 1/20 0.50
▸ KMT2A Q03164 5/20 0.49
▸ SMN1; SMN2 Q16637 4/20 0.49
▸ PKM P14618 2/20 0.49
▸ RAB9A P51151 4/20 0.48
▸ NPC1 O15118 3/20 0.48
▸ GAA P10253 2/20 0.48
▸ HPGD P15428 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ MEN1 O00255 4/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ KCNK3 O14649 1/20 0.48
▸ KCNK9 Q9NPC2 1/20 0.48
▸ TP53 P04637 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ FLT1 P17948 1/20 0.47
▸ KDR P35968 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16454876 0.86 NPC1 (0.55) PIK3CDPIK3CAPIK3CBKMT2ASMN1; SMN2
SCHEMBL16454878 0.81 LMNA (0.51) PIK3CDPIK3CAPIK3CBKMT2ASMN1; SMN2
SCHEMBL16454875 0.79 KCNK3 (0.53) PIK3CDPIK3CAPIK3CBKMT2ASMN1; SMN2
SCHEMBL16454828 0.77 FADS1 (0.51) KMT2ASMN1; SMN2RAB9ANPC1MEN1
SCHEMBL16454823 0.77 NPC1 (0.55) KMT2ASMN1; SMN2RAB9ANPC1MEN1
SCHEMBL8814916 0.77 L3MBTL1 (0.80) KMT2ASMN1; SMN2PKMGAAHTT
SCHEMBL16454801 0.73 MAPT (0.50) KMT2ASMN1; SMN2RAB9ANPC1GAA
SCHEMBL16454830 0.72 MAPT (0.50) PIK3CDPIK3CAPIK3CBSMN1; SMN2RAB9A
SCHEMBL16454787 0.72 SMO (0.54) KMT2ASMN1; SMN2RAB9ANPC1HPGD
SCHEMBL259421 0.71 KCNK3 (0.86) KMT2ASMN1; SMN2PKMRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015020565-A1 SUBSTITUTED [1,2,4]TRIAZOLO[4,3-A]PYRIDINES EXHIBITING ANTAGONIST PROPERTIES TO ADENOSINE A2A RECEPTORS, AND USE THEREOF ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НЬЮВАК" (ООО "НЬЮВАК") (RU) 2015-02-12 — — WO disclosed
Send feedback